Northwire Canada EditionFriday, July 10, 2026
Northwire
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2%
Financings Routine −

Promino Announces Settlements and Amendments of Convertible Debentures

MUSL · Price

Executive Summary

  • Promino Nutritional Sciences settled $373,910 in principal and accrued interest on convertible debentures by issuing 5,341,566 common shares at a deemed price of $0.07 per share.
  • The company amended the terms of certain convertible debentures with an aggregate principal amount of $711,500, extending their maturity dates by two years and significantly reducing the conversion price.

Key Details

  • Settlement of $373,910 in principal and accrued interest executed via issuance of 5,341,566 common shares.
  • Deemed issue price for settlement shares: $0.07 per common share.
  • Amendment applies to convertible debentures originally issued on June 30 and July 14, 2023, with an aggregate principal amount of $711,500.
  • Maturity dates extended by two years to June 30, 2027, and July 14, 2027.
  • Conversion price amended from $0.30 per unit to $0.07 per common share.
  • Ticker symbols referenced: CSE: MUSL, OTCID: MUSLF, FSE: 93X.
Read the original news release →

More from Promino Nutritional Sciences Inc